Amarin Corp Plc (AMRN)

[ggwpq]

Thanks JL, I re-read Amarin's June 1st presentation (see link),
on p.5 it says no benefit for subgroup of low HDL for both AIM-HIGH and ACCORD while benefit for subgroup of high TG & low HDL. That further confirms with multiple genetic studies results on p.9. That argues Vs Kiwi's thesis of enrolling patients with low HDL is better for R-IT trial success.



http://files.shareholder.com/downloads/AMRN/3172500589x0x799267/B882FB49-4910-4F4D-9534-301ED99C78ED/Amarin_Investor_Presentation_Jun_2015.pdf